Trial Profile
Safety and efficacy of collagenase clostridium histolyticum in patients with Peyronie's disease
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Feb 2018
Price :
$35
*
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Peyronie's disease
- Focus Adverse reactions; Therapeutic Use
- 16 Feb 2018 New trial record